Author:
Barkan Güliz A.,Pambuccian Stefan E.
Publisher
Springer International Publishing
Reference40 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
2. Power NE, Izawa J. Comparison of guidelines on non-muscle invasive bladder Cancer (EAU, CUA, AUA, NCCN, NICE). Bladder Cancer. 2016;2(1):27–36.
3. Yafi FA, Brimo F, Auger M, Aprikian A, Tanguay S, Kassouf W. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urol Oncol. 2014;32(1):27.e21–6.
4. Amin MB, Smith SC, Reuter VE, et al. Update for the practicing pathologist: the international consultation on urologic disease-European association of urology consultation on bladder cancer. Mod Pathol. 2015;28(5):612–30.
5. Wojcik EM. Urine cytology, DNA ploidy and morphometry. In: Lokeshwar VB, editor. Bladder tumors: molecular aspects and clinical management, cancer drug discovery and development. New York: Springer Science+Business Media; 2011. p. 79–90.